ID   FUMH_HUMAN              Reviewed;         510 AA.
AC   P07954; B1ANK7;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 3.
DT   15-MAR-2017, entry version 201.
DE   RecName: Full=Fumarate hydratase, mitochondrial;
DE            Short=Fumarase;
DE            EC=4.2.1.2;
DE   Flags: Precursor;
GN   Name=FH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Gellera C., Baratta S., Cavadini P., Invernizzi F., Lamantea E.,
RA   Didonato S., Taroni F.;
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bourgeron T., Parfait B., Chretien D., Rotig A., Munnich A.,
RA   Rustin P.;
RT   "Complete cDNA sequence of the human fumarase.";
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 44-510.
RC   TISSUE=Liver;
RX   PubMed=3828494; DOI=10.1007/BF01116247;
RA   Kinsella B.T., Doonan S.;
RT   "Nucleotide sequence of a cDNA coding for mitochondrial fumarase from
RT   human liver.";
RL   Biosci. Rep. 6:921-929(1986).
RN   [8]
RP   PROTEIN SEQUENCE OF 269-286 AND 422-444, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-66; LYS-80; LYS-94; LYS-256
RP   AND LYS-292, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=22509282; DOI=10.1371/journal.pone.0034237;
RA   von Lohneysen K., Scott T.M., Soldau K., Xu X., Friedman J.S.;
RT   "Assessment of the red cell proteome of young patients with
RT   unexplained hemolytic anemia by two-dimensional differential in-gel
RT   electrophoresis (DIGE).";
RL   PLoS ONE 7:E34237-E34237(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 44-510, AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human fumarate hydratase.";
RL   Submitted (DEC-2012) to the PDB data bank.
RN   [17]
RP   VARIANT FMRD THR-308.
RA   Coughlin E.M., Chalmers R.A., Slaugenhaupt S.A., Gusella J.F.,
RA   Shih V.E., Ramesh V.;
RT   "Identification of a molecular defect in a fumarase deficient patient
RT   and mapping of the fumarase gene.";
RL   Am. J. Hum. Genet. 53:A896-A896(1993).
RN   [18]
RP   VARIANTS FMRD ARG-230; THR-308; CYS-312 AND VAL-425.
RX   PubMed=9635293; DOI=10.1006/mgme.1998.2684;
RA   Coughlin E.M., Christensen E., Kunz P.L., Krishnamoorthy K.S.,
RA   Walker V., Dennis N.R., Chalmers R.A., Elpeleg O.N., Whelan D.,
RA   Pollitt R.J., Ramesh V., Mandell R., Shih V.E.;
RT   "Molecular analysis and prenatal diagnosis of human fumarase
RT   deficiency.";
RL   Mol. Genet. Metab. 63:254-262(1998).
RN   [19]
RP   VARIANTS HLRCC THR-107; PRO-117; ARG-180; ARG-185; ARG-230; HIS-233;
RP   VAL-282 AND ARG-328.
RX   PubMed=11865300; DOI=10.1038/ng849;
RA   Tomlinson I.P.M., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E.M.,
RA   Kelsell D., Leigh I., Gorman P., Lamlum H., Rahman S., Roylance R.R.,
RA   Olpin S., Bevan S., Barker K., Hearle N., Houlston R.S., Kiuru M.,
RA   Lehtonen R., Karhu A., Vilkki S., Laiho P., Eklund C., Vierimaa O.,
RA   Aittomaeki K., Hietala M., Sistonen P., Paetau A., Salovaara R.,
RA   Herva R., Launonen V., Aaltonen L.A.;
RT   "Germline mutations in FH predispose to dominantly inherited uterine
RT   fibroids, skin leiomyomata and papillary renal cell cancer.";
RL   Nat. Genet. 30:406-410(2002).
CC   -!- FUNCTION: Also acts as a tumor suppressor.
CC   -!- CATALYTIC ACTIVITY: (S)-malate = fumarate + H(2)O.
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; (S)-
CC       malate from fumarate: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|Ref.16}.
CC   -!- INTERACTION:
CC       P11309:PIM1; NbExp=3; IntAct=EBI-1050358, EBI-696621;
CC   -!- SUBCELLULAR LOCATION: Isoform Mitochondrial: Mitochondrion.
CC   -!- SUBCELLULAR LOCATION: Isoform Cytoplasmic: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Mitochondrial;
CC         IsoId=P07954-1; Sequence=Displayed;
CC       Name=Cytoplasmic;
CC         IsoId=P07954-2; Sequence=VSP_018965;
CC         Note=Initiator Met-1 is removed. Contains a N-acetylalanine at
CC         position 2 (By similarity). {ECO:0000250};
CC   -!- TISSUE SPECIFICITY: Expressed in red blood cells; underexpressed
CC       in red blood cells (cytoplasm) of patients with hereditary non-
CC       spherocytic hemolytic anemia of unknown etiology.
CC       {ECO:0000269|PubMed:22509282}.
CC   -!- DISEASE: Fumarase deficiency (FMRD) [MIM:606812]: A severe
CC       autosomal recessive metabolic disorder characterized by early-
CC       onset hypotonia, profound psychomotor retardation, and brain
CC       abnormalities, such as agenesis of the corpus callosum, gyral
CC       defects, and ventriculomegaly. Many patients show neonatal
CC       distress, metabolic acidosis, and/or encephalopathy.
CC       {ECO:0000269|PubMed:9635293, ECO:0000269|Ref.17}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Hereditary leiomyomatosis and renal cell cancer (HLRCC)
CC       [MIM:150800]: A disorder characterized by predisposition to
CC       cutaneous and uterine leiomyomas, and papillary type 2 renal
CC       cancer which occurs in about 20% of patients.
CC       {ECO:0000269|PubMed:11865300}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: There are 2 substrate-binding sites: the catalytic
CC       A site, and the non-catalytic B site that may play a role in the
CC       transfer of substrate or product between the active site and the
CC       solvent. Alternatively, the B site may bind allosteric effectors
CC       (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the class-II fumarase/aspartase family.
CC       Fumarase subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=TCA Cycle Gene Mutation Database;
CC       URL="http://databases.lovd.nl/shared/genes/FH";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FHID40573ch1q42.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U59309; AAB66354.1; -; mRNA.
DR   EMBL; U48857; AAD00071.1; -; mRNA.
DR   EMBL; BT009839; AAP88841.1; -; mRNA.
DR   EMBL; AK312415; BAG35325.1; -; mRNA.
DR   EMBL; CH471098; EAW70092.1; -; Genomic_DNA.
DR   EMBL; BC003108; AAH03108.1; -; mRNA.
DR   EMBL; BC017444; AAH17444.1; -; mRNA.
DR   EMBL; M15502; AAA52483.1; -; mRNA.
DR   CCDS; CCDS1617.1; -. [P07954-1]
DR   PIR; S06213; UFHUM.
DR   RefSeq; NP_000134.2; NM_000143.3. [P07954-1]
DR   UniGene; Hs.592490; -.
DR   PDB; 3E04; X-ray; 1.95 A; A/B/C/D=44-510.
DR   PDB; 5D6B; X-ray; 2.10 A; A=49-510.
DR   PDBsum; 3E04; -.
DR   PDBsum; 5D6B; -.
DR   ProteinModelPortal; P07954; -.
DR   SMR; P07954; -.
DR   BioGrid; 108562; 77.
DR   DIP; DIP-46920N; -.
DR   IntAct; P07954; 20.
DR   MINT; MINT-5005927; -.
DR   STRING; 9606.ENSP00000355518; -.
DR   iPTMnet; P07954; -.
DR   PhosphoSitePlus; P07954; -.
DR   SwissPalm; P07954; -.
DR   BioMuta; FH; -.
DR   DMDM; 1730117; -.
DR   REPRODUCTION-2DPAGE; IPI00296053; -.
DR   SWISS-2DPAGE; P07954; -.
DR   UCD-2DPAGE; P07954; -.
DR   EPD; P07954; -.
DR   MaxQB; P07954; -.
DR   PaxDb; P07954; -.
DR   PeptideAtlas; P07954; -.
DR   PRIDE; P07954; -.
DR   TopDownProteomics; P07954-2; -. [P07954-2]
DR   DNASU; 2271; -.
DR   Ensembl; ENST00000366560; ENSP00000355518; ENSG00000091483. [P07954-1]
DR   GeneID; 2271; -.
DR   KEGG; hsa:2271; -.
DR   UCSC; uc001hyx.4; human. [P07954-1]
DR   CTD; 2271; -.
DR   DisGeNET; 2271; -.
DR   GeneCards; FH; -.
DR   GeneReviews; FH; -.
DR   HGNC; HGNC:3700; FH.
DR   HPA; CAB017785; -.
DR   HPA; HPA025770; -.
DR   HPA; HPA025948; -.
DR   HPA; HPA027341; -.
DR   MalaCards; FH; -.
DR   MIM; 136850; gene.
DR   MIM; 150800; phenotype.
DR   MIM; 606812; phenotype.
DR   neXtProt; NX_P07954; -.
DR   OpenTargets; ENSG00000091483; -.
DR   Orphanet; 24; Fumaric aciduria.
DR   Orphanet; 523; Hereditary leiomyomatosis and renal cell cancer.
DR   Orphanet; 29072; Hereditary pheochromocytoma-paraganglioma.
DR   PharmGKB; PA28139; -.
DR   eggNOG; KOG1317; Eukaryota.
DR   eggNOG; COG0114; LUCA.
DR   GeneTree; ENSGT00390000002779; -.
DR   HOGENOM; HOG000061736; -.
DR   HOVERGEN; HBG002183; -.
DR   InParanoid; P07954; -.
DR   KO; K01679; -.
DR   OMA; FAYLKKA; -.
DR   OrthoDB; EOG091G05UL; -.
DR   PhylomeDB; P07954; -.
DR   TreeFam; TF300441; -.
DR   BioCyc; MetaCyc:ENSG00000091483-MONOMER; -.
DR   BRENDA; 4.2.1.2; 2681.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   UniPathway; UPA00223; UER01007.
DR   EvolutionaryTrace; P07954; -.
DR   GenomeRNAi; 2271; -.
DR   PRO; PR:P07954; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000091483; -.
DR   CleanEx; HS_FH; -.
DR   ExpressionAtlas; P07954; baseline and differential.
DR   Genevisible; P07954; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0045239; C:tricarboxylic acid cycle enzyme complex; IEA:InterPro.
DR   GO; GO:0004333; F:fumarate hydratase activity; EXP:Reactome.
DR   GO; GO:0006106; P:fumarate metabolic process; IBA:GO_Central.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl.
DR   GO; GO:0006108; P:malate metabolic process; IBA:GO_Central.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IBA:GO_Central.
DR   Gene3D; 1.10.275.10; -; 1.
DR   HAMAP; MF_00743; FumaraseC; 1.
DR   InterPro; IPR005677; Fum_hydII.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR018951; Fumarase_C_C.
DR   InterPro; IPR020557; Fumarate_lyase_CS.
DR   InterPro; IPR000362; Fumarate_lyase_fam.
DR   InterPro; IPR022761; Fumarate_lyase_N.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   PANTHER; PTHR11444; PTHR11444; 1.
DR   Pfam; PF10415; FumaraseC_C; 1.
DR   Pfam; PF00206; Lyase_1; 1.
DR   PRINTS; PR00149; FUMRATELYASE.
DR   SUPFAM; SSF48557; SSF48557; 1.
DR   TIGRFAMs; TIGR00979; fumC_II; 1.
DR   PROSITE; PS00163; FUMARATE_LYASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disease mutation; Lyase;
KW   Mitochondrion; Phosphoprotein; Reference proteome; Transit peptide;
KW   Tricarboxylic acid cycle; Tumor suppressor.
FT   TRANSIT       1     44       Mitochondrion. {ECO:0000250}.
FT   CHAIN        45    510       Fumarate hydratase, mitochondrial.
FT                                /FTId=PRO_0000010319.
FT   REGION      176    179       B site. {ECO:0000250}.
FT   REGION      186    188       Substrate binding. {ECO:0000250}.
FT   BINDING     147    147       Substrate. {ECO:0000250}.
FT   MOD_RES      61     61       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES      61     61       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES      66     66       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      66     66       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES      80     80       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      80     80       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES      85     85       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES      90     90       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      94     94       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     115    115       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     115    115       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     122    122       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     122    122       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     213    213       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     223    223       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     223    223       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     256    256       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     292    292       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     292    292       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     366    366       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     467    467       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     473    473       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   MOD_RES     502    502       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P97807}.
FT   VAR_SEQ       1     43       Missing (in isoform Cytoplasmic).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018965.
FT   VARIANT     107    107       N -> T (in HLRCC; dbSNP:rs121913121).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013497.
FT   VARIANT     117    117       A -> P (in HLRCC).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013498.
FT   VARIANT     180    180       H -> R (in HLRCC; dbSNP:rs863224015).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013499.
FT   VARIANT     185    185       Q -> R (in HLRCC; dbSNP:rs779707997).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013500.
FT   VARIANT     230    230       K -> R (in FMRD and HLRCC;
FT                                dbSNP:rs752232718).
FT                                {ECO:0000269|PubMed:11865300,
FT                                ECO:0000269|PubMed:9635293}.
FT                                /FTId=VAR_002445.
FT   VARIANT     233    233       R -> H (in HLRCC; dbSNP:rs28933069).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013501.
FT   VARIANT     282    282       G -> V (in HLRCC).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013502.
FT   VARIANT     308    308       A -> T (in FMRD; dbSNP:rs121913118).
FT                                {ECO:0000269|PubMed:9635293,
FT                                ECO:0000269|Ref.17}.
FT                                /FTId=VAR_002446.
FT   VARIANT     312    312       F -> C (in FMRD).
FT                                {ECO:0000269|PubMed:9635293}.
FT                                /FTId=VAR_002447.
FT   VARIANT     328    328       M -> R (in HLRCC).
FT                                {ECO:0000269|PubMed:11865300}.
FT                                /FTId=VAR_013503.
FT   VARIANT     425    425       D -> V (in FMRD).
FT                                {ECO:0000269|PubMed:9635293}.
FT                                /FTId=VAR_002448.
FT   STRAND       50     55       {ECO:0000244|PDB:3E04}.
FT   STRAND       58     63       {ECO:0000244|PDB:3E04}.
FT   HELIX        70     78       {ECO:0000244|PDB:3E04}.
FT   HELIX        84     86       {ECO:0000244|PDB:3E04}.
FT   HELIX        90    106       {ECO:0000244|PDB:3E04}.
FT   HELIX       107    110       {ECO:0000244|PDB:3E04}.
FT   HELIX       114    128       {ECO:0000244|PDB:3E04}.
FT   HELIX       133    135       {ECO:0000244|PDB:3E04}.
FT   STRAND      139    142       {ECO:0000244|PDB:3E04}.
FT   HELIX       147    164       {ECO:0000244|PDB:3E04}.
FT   HELIX       177    181       {ECO:0000244|PDB:3E04}.
FT   TURN        182    184       {ECO:0000244|PDB:3E04}.
FT   HELIX       187    205       {ECO:0000244|PDB:3E04}.
FT   HELIX       207    224       {ECO:0000244|PDB:3E04}.
FT   TURN        225    227       {ECO:0000244|PDB:3E04}.
FT   STRAND      229    234       {ECO:0000244|PDB:3E04}.
FT   STRAND      237    243       {ECO:0000244|PDB:3E04}.
FT   HELIX       244    264       {ECO:0000244|PDB:3E04}.
FT   TURN        267    269       {ECO:0000244|PDB:3E04}.
FT   STRAND      270    272       {ECO:0000244|PDB:3E04}.
FT   TURN        277    279       {ECO:0000244|PDB:3E04}.
FT   HELIX       289    301       {ECO:0000244|PDB:3E04}.
FT   HELIX       311    316       {ECO:0000244|PDB:3E04}.
FT   HELIX       319    345       {ECO:0000244|PDB:3E04}.
FT   STRAND      349    352       {ECO:0000244|PDB:3E04}.
FT   STRAND      366    368       {ECO:0000244|PDB:3E04}.
FT   HELIX       375    399       {ECO:0000244|PDB:3E04}.
FT   HELIX       409    433       {ECO:0000244|PDB:3E04}.
FT   HELIX       435    437       {ECO:0000244|PDB:3E04}.
FT   HELIX       442    451       {ECO:0000244|PDB:3E04}.
FT   HELIX       454    459       {ECO:0000244|PDB:3E04}.
FT   HELIX       460    463       {ECO:0000244|PDB:3E04}.
FT   HELIX       465    478       {ECO:0000244|PDB:3E04}.
FT   HELIX       482    488       {ECO:0000244|PDB:3E04}.
FT   HELIX       494    500       {ECO:0000244|PDB:3E04}.
FT   HELIX       503    505       {ECO:0000244|PDB:3E04}.
FT   STRAND      506    508       {ECO:0000244|PDB:5D6B}.
SQ   SEQUENCE   510 AA;  54637 MW;  86F91F95DC046F64 CRC64;
     MYRALRLLAR SRPLVRAPAA ALASAPGLGG AAVPSFWPPN AARMASQNSF RIEYDTFGEL
     KVPNDKYYGA QTVRSTMNFK IGGVTERMPT PVIKAFGILK RAAAEVNQDY GLDPKIANAI
     MKAADEVAEG KLNDHFPLVV WQTGSGTQTN MNVNEVISNR AIEMLGGELG SKIPVHPNDH
     VNKSQSSNDT FPTAMHIAAA IEVHEVLLPG LQKLHDALDA KSKEFAQIIK IGRTHTQDAV
     PLTLGQEFSG YVQQVKYAMT RIKAAMPRIY ELAAGGTAVG TGLNTRIGFA EKVAAKVAAL
     TGLPFVTAPN KFEALAAHDA LVELSGAMNT TACSLMKIAN DIRFLGSGPR SGLGELILPE
     NEPGSSIMPG KVNPTQCEAM TMVAAQVMGN HVAVTVGGSN GHFELNVFKP MMIKNVLHSA
     RLLGDASVSF TENCVVGIQA NTERINKLMN ESLMLVTALN PHIGYDKAAK IAKTAHKNGS
     TLKETAIELG YLTAEQFDEW VKPKDMLGPK
//
